Chemed
403 hedge funds and large institutions have $6.5B invested in Chemed in 2021 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 103 increasing their positions, 167 reducing their positions, and 59 closing their positions.
383% more call options, than puts
Call options by funds: $15.1M | Put options by funds: $3.12M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
1.57% more ownership
Funds ownership: 87.35% → 88.92% (+1.6%)
1% less capital invested
Capital invested by funds: $6.6B → $6.5B (-$93.3M)
5% less funds holding
Funds holding: 425 → 403 (-22)
27% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 59
38% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 167
Top Buyers
Top Sellers
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$100M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$47.7M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$43.9M |
| 4 |
Goldman Sachs
New York
|
-$34.5M |
| 5 |
BlackRock
New York
|
-$28.6M |
CHE Hedge Fund Activity: Q3 2021 in Review
403 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2021, worth a combined $6.5B — down 1.4% from $6.6B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of CHE and 43 opened new positions — a net loss of 16 holders — while 167 trimmed existing stakes and 103 added.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $200M. The largest seller was Riverbridge Partners, cutting an estimated $100M.
- 403 institutional investors held Chemed (CHE) as of Q3 2021, down from 425 in Q2 2021.
- Funds reported $6.5B of Chemed stock for Q3 2021, down 1.4% quarter-over-quarter.
- 43 funds opened new Chemed positions in Q3 2021 and 59 closed out, a net change of -16 holders.
- The largest Chemed buyer in Q3 2021 was Wellington Management Group, an estimated $200M added.
- The largest Chemed seller in Q3 2021 was Riverbridge Partners, an estimated $100M sold.
Based on aggregated 13F filings for Q3 2021.